Nearly all the riboflavin (vitamin B2) in supplements, fortified foods, and animal feed is made by fermentation, using microorganisms that have been engineered to overproduce the vitamin. This biological manufacturing process has largely replaced the older chemical synthesis route because it’s cheaper, more efficient, and generates less waste. The best industrial strains now produce up to 30 grams of riboflavin per liter of fermentation broth in about three days.
The Two Microorganisms That Dominate Production
Commercial riboflavin production relies on two main organisms: a yeast-like mold called Ashbya gossypii and a bacterium called Bacillus subtilis. Both naturally produce riboflavin, but wild strains make far too little for industrial purposes. Through decades of genetic optimization, manufacturers have pushed these organisms to produce hundreds of times more than they would on their own.
B. subtilis is currently the more competitive producer. Recombinant strains can yield around 27 to 30 grams per liter, and fermentation runs complete in roughly three days. A. gossypii produces over 13 grams per liter and remains widely used, particularly by major producers like BASF in Germany. A third organism, a yeast called Candida famata, can reach about 20 grams per liter but has fallen out of favor because its fermentation process tends to be unstable. Global production is dominated by a handful of companies, including BASF, DSM (formerly Roche), and Chinese manufacturers Hubei Guangji and Shanghai Acebright.
What Happens Inside the Fermenter
The basic process is conceptually simple: microorganisms are fed nutrients in large fermentation tanks, and they convert those raw materials into riboflavin as a byproduct of their metabolism. The organisms use sugar (typically glucose) as their primary carbon source, along with nitrogen sources and minerals. As the cells grow and multiply, they synthesize riboflavin internally and, in optimized strains, secrete large quantities of it into the surrounding liquid.
Inside each cell, the biological pathway that builds riboflavin starts with two simple precursors: GTP (one of the building blocks of DNA and RNA) and a sugar-derived molecule called ribulose 5-phosphate. Seven different enzymes work in sequence to transform these starting materials. GTP gets stripped down and reshaped through several intermediate steps. Meanwhile, ribulose 5-phosphate is converted into a separate four-carbon fragment. These two branches converge when an enzyme called lumazine synthase fuses them together. In the final step, riboflavin synthase takes two of these fused molecules and, in an unusual reaction, cannibalizes one to complete the other, producing one finished riboflavin molecule and recycling the leftover piece back into the pathway.
How Genetic Engineering Boosts Output
Wild microorganisms produce only as much riboflavin as they need for their own survival, which is a tiny amount. Industrial strains are engineered with multiple genetic changes that force the cell to massively overproduce.
The most direct approach is overexpressing the genes that encode the riboflavin-building enzymes, essentially giving the cell extra copies so it runs the production line faster. But that alone isn’t enough. Engineers also redirect the cell’s overall metabolism to funnel more raw material toward riboflavin. For example, overexpressing an enzyme called glucose-6-phosphate dehydrogenase pushes more sugar through the pentose phosphate pathway, which generates the ribulose 5-phosphate precursor. Deleting genes for competing metabolic routes has a similar effect, blocking off-ramps so more carbon flows where it’s needed.
On the GTP supply side, boosting the expression of key genes in the purine synthesis pathway (the route cells use to make GTP) has increased riboflavin output by as much as 31% in B. subtilis. Another clever trick involves the cell’s own regulatory system. Cells normally use a molecular switch called a riboswitch to sense when they’ve made enough riboflavin and shut down production. Deleting or mutating this riboswitch removes the brake, allowing the cell to keep producing even when riboflavin levels are already high. Engineers have also reduced the cell’s ability to convert riboflavin into its active coenzyme forms, which prevents the finished product from being consumed internally.
The Older Chemical Synthesis Route
Before fermentation took over, riboflavin was manufactured through a multi-step chemical process. The synthesis starts with D-ribose (a simple sugar) reacting with a chemical called 3,4-xylidine in methanol to form an intermediate called riboside. That intermediate is then chemically reduced, coupled with another reactive compound, and finally combined with barbituric acid in a ring-closing reaction that yields riboflavin. This process requires organic solvents and multiple purification steps, making it more expensive and less environmentally friendly than fermentation. It has been almost entirely phased out of large-scale production.
Purification and Quality Standards
After fermentation, the riboflavin must be separated from the broth of cells, leftover nutrients, and metabolic byproducts. The vitamin’s intense yellow color and low solubility in water actually help here: riboflavin crystallizes relatively easily, which allows manufacturers to isolate it through filtration and recrystallization steps. The final product is a bright yellow-orange powder.
Food-grade riboflavin must meet the standards set by the Food Chemical Codex (FCC), which requires a purity between 98% and 102%. This grade is approved for use in foods, beverages, and nutritional supplements. Pharmaceutical-grade riboflavin follows similar or tighter specifications under USP standards.
Riboflavin From Your Gut Bacteria
Your body can’t synthesize riboflavin on its own, but some of the bacteria living in your gut can. When researchers incubated human fecal samples in the lab, riboflavin accumulated during the first 16 hours regardless of which bacterial strains were added, confirming that multiple species of gut microbiota contribute to production. Among well-studied beneficial bacteria, only a small fraction of Bifidobacterium species carry the complete set of genes needed for riboflavin synthesis. Out of 83 bifidobacterial species examined, just 16 had the full genetic toolkit, and most of those were species found in primates.
The amounts produced by gut bacteria are extremely small compared to what you need. A well-studied strain of Bifidobacterium longum subsp. infantis produced less than 0.2 nanograms per milliliter in culture. Even a mutant version engineered to overproduce reached only about 61 nanograms per milliliter. For context, adult men need 1.3 milligrams of riboflavin daily and adult women need 1.1 milligrams. Gut bacteria contribute some riboflavin to your body’s supply, but nowhere near enough to meet your daily needs without dietary sources.

